site stats

Immunic market cap

Witryna15 kwi 2024 · Aegis Capital bewertet die Aktie positiv mit einem Kauf-Rating. 22 März 2024 ... Veganer Markt. Rating nach Charttechnik. Überverkaufte Aktien. Überkaufte Aktien. Nahe am Widerstand. ... News auf Englisch zu IMMUNIC, INC. 13.03. Immunic, Inc. : Regulation FD Disclosure (form 8-K) AQ. 23.02. Immunic : Q4 2024 News … WitrynaImmunic (IMUX) - Net assets Net assets on the balance sheet as of December 2024 : $0.11 B. According to Immunic's latest financial reports the company has $0.11 B in …

Witryna15 kwi 2024 · Stock split history for Immunic (IMUX) Immunic stock (symbol: IMUX) underwent a total of 1 stock split. The stock split occured on April 15th, 2024. ... The … WitrynaAktien, Aktienkurse, Devisenkurse und Währungsrechner, Rohstoffkurse. Informationen rund um die Börse zu Aktie, Fonds und ETFs. Börsenkurse für Optionsscheine und Zertifikate. Aktienanalysen - finanzen.net iphone waterproof case 5s https://mimounted.com

IMMUNIC, INC. : Kurs Aktie Börse A2PHD4 US4525EP1011

Witryna3 sty 2024 · About Immunic, Inc. 11440 WEST BERNARDO COURT SUITE 300, SAN DIEGO, California, 92127, United States +49 89 2500794 60 https:/www.imux.com. … WitrynaAs of February 2024 Immunic's TTM earnings are -$83.89 M. companies: 7,303 total market cap: $84.738 T. Global ranking; Ranking by countries. America ... The … Witryna10 godz. temu · Mark Mobius, seasoned investor and founder of Mobius Capital, believes that the concerns around the Indian ports-to-energy conglomerate Adani Group were overblown by Hindenburg Research, the ... iphone wav 変換

Immunic Inc. (IMUX) Stock is expected to generate profits in the …

Category:Immunic Reports Positive Data from Maintenance Phase of Phase …

Tags:Immunic market cap

Immunic market cap

Immunic (IMUX) - Stock split history

Witryna3 lis 2024 · Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update. News provided by. Immunic, Inc. Nov 03, 2024, 06:30 ET. – $72.8 Million in Cash and Cash Equivalents as ... Witryna15 kwi 2024 · The company has been renamed Immunic, Inc. and its common stock is expected to commence trading on The Nasdaq Capital Market under the ticker symbol "IMUX" on April 15, 2024. Immunic, Inc. is a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic …

Immunic market cap

Did you know?

Witryna1 dzień temu · Immunic Inc CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase... April 13, 2024 WitrynaImmunic market cap history and chart from 2013 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Immunic market cap as of September 23, 2024 is $0.1B .

WitrynaImmunic (IMUX) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Enterprise Value/Market Cap N/A. Enterprise Value/Revenue N/A. Enterprise Value/Gross Profit-10.00T> Enterprise Value/Ebitda 0.53. Forecast. 1Y Price Target. … Witryna14 kwi 2024 · Immunic Inc (IMUX) is down -5.26%% today. IMUX has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on IMUX!See Full IMUX ReportIMUX stock closed at $1.52 ...

WitrynaImmunic Therapeutics has raised a total of $284.4M in funding over 9 rounds. Their latest funding was raised on Oct 10, 2024 from a Post-IPO Equity round. Immunic Therapeutics is registered under the ticker NASDAQ:IMUX . Immunic Therapeutics is funded by 21 investors. Vivo Capital and RTW Investments are the most recent … Witryna10 godz. temu · Mark Mobius, seasoned investor and founder of Mobius Capital, believes that the concerns around the Indian ports-to-energy conglomerate Adani …

WitrynaMarket Cap-1M Daily Avg. Vol-3Y P/B Range - 52W Range - 3Y P/S Range - 3Y DivYield Range - Company Info. more arrow_right. Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerat...

WitrynaImmunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing three small molecule … iphone waveファイル 取り込みWitrynaChardan Capital Markets: Buy: $40: Show Previous Ratings Apr-13-23 08:00AM: Immunic gets a "positive surprise" from lead asset trial. News Direct. Apr-06-23 02:10PM: Immunic's (IMUX) Ulcerative Colitis Study Shows Positive Data ... Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral … iphone wave backgroundWitryna3 lis 2024 · Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update. PR Newswire. November 3, 2024, 3:30 AM · 16 min read. – $72.8 Million in Cash and Cash Equivalents as ... iphone waveWitryna12 kwi 2024 · The company has been renamed Immunic, Inc. and its common stock is expected to commence trading on The Nasdaq Capital Market under the ticker symbol "IMUX" on April 15, 2024. Immunic, Inc. is a ... orange rachael ray cookwareWitryna21 paź 2024 · Four months after taking an axe to the pipeline resulting from a Phase II miss, Immunic is back with another miss. ... RBC Capital Markets’ Healthcare Technology Analyst, Sean Dodge, spotlights ... orange racerbackWitrynaAs of March 2024 Immunic has a market cap of $70.15 Million . This makes Immunic the world's 6697th most valuable company by market cap according to our data. The … iphone wave wallpaperWitrynaHistorical daily share price chart and data for Immunic since 2024 adjusted for splits. The latest closing stock price for Immunic as of February 27, 2024 is 1.89.. The all-time high Immunic stock closing price was 1332.40 on June 16, 2014.; The Immunic 52-week high stock price is 12.64, which is 568.8% above the current share price.; The … iphone wave 録音